ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,165Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 676

$1.01M Total Retail Price of All Prescriptions

Rank: 56 out of 676

606 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 606 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

10% of this provider’s 606 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 22,774 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 1,205 1,085 1 2
FUROSEMIDE 1,065 973 2 4
AMLODIPINE BESYLATE 796 749 3 3
POTASSIUM CHLORIDE 753 711 4 9
GABAPENTIN 682 558 5 10
METFORMIN HCL 644 530 6 8
LISINOPRIL 616 532 7 5
LEVOTHYROXINE SODIUM 585 522 8 7
HYDROCHLOROTHIAZIDE 583 480 9 12
SIMVASTATIN 555 496 10 6
METOPROLOL TARTRATE 486 437 11 22
WARFARIN SODIUM 475 413 12 18
MELOXICAM 466 396 13 13
PRAVASTATIN SODIUM 449 393 14 11
DONEPEZIL HCL 419 419 15 24
TRAMADOL HCL 393 370 16 19
METOPROLOL SUCCINATE 357 314 17 14
CLOPIDOGREL 320 296 18 28
RANITIDINE HCL 303 278 19 27
ZOLPIDEM TARTRATE 279 230 20 21
CLONIDINE HCL 278 209 21 32
GLIMEPIRIDE 266 226 22 30
HYDROCODONE-ACETAMINOPHEN 262 169 S3 23 1
DIGOXIN 255 243 24 52
PLAVIX 248 234 25 40
ATORVASTATIN CALCIUM 245 197 26 20
ATENOLOL 240 221 27 25
SERTRALINE HCL 238 212 28 26
LOSARTAN POTASSIUM 223 205 29 34
NAMENDA 221 221 30 35
CITALOPRAM HBR 219 207 31 17
ALLOPURINOL 215 209 32 31
FLUTICASONE PROPIONATE 214 189 33 49
CARVEDILOL 211 196 34 15
MIRTAZAPINE 175 175 35 59
TAMSULOSIN HCL 172 146 36 38
ROPINIROLE HCL 164 151 37 85
AMITRIPTYLINE HCL 163 88 R 38 46
NEXIUM 160 96 39 23
OXYBUTYNIN CHLORIDE 158 134 40 149
TRIAMTERENE-HCTZ 157 156 41 43
DOXYCYCLINE HYCLATE 156 126 42 82
QUETIAPINE FUMARATE 155 135 43 72
ISOSORBIDE MONONITRATE ER 150 132 44 54
MECLIZINE HCL 147 135 45 83
LISINOPRIL-HYDROCHLOROTHIAZIDE 145 132 46 16
NIFEDIPINE ER 133 119 47 100
DILTIAZEM ER 126 115 48 118
CIPROFLOXACIN HCL 123 104 49 45
DIVALPROEX SODIUM 123 97 49 99
PAROXETINE HCL 122 105 51 65
GLYBURIDE 119 97 R 52 92
METOCLOPRAMIDE HCL 118 98 53 107
ZETIA 115 91 54 89
PROPRANOLOL HCL 115 98 54 120
LIPITOR 110 92 56 94
DIOVAN 109 109 57 37
SYNTHROID 106 103 58 48
PREDNISONE 104 78 59 53
EVISTA 104 104 59 119
BENAZEPRIL HCL 104 94 59 58
ALENDRONATE SODIUM 101 89 62 61
LANTUS 98 75 63 55
FAMOTIDINE 98 95 63 64
ENALAPRIL MALEATE 96 73 65 65
POLYETHYLENE GLYCOL 3350 93 79 66 56
GLIPIZIDE 92 61 67 81
LEVETIRACETAM 90 72 68 138
COLCRYS 89 89 69 122
ESCITALOPRAM OXALATE 88 79 70 73
PREMARIN 87 69 R 71 128
NOVOLIN R 86 78 72 153
SEROQUEL 85 70 73 135
SULFAMETHOXAZOLE-TRIMETHOPRIM 84 66 74 74
AZITHROMYCIN 83 73 75 39
DILTIAZEM 24HR CD 83 83 75 152
METFORMIN HCL ER 82 71 77 63
CEPHALEXIN 82 76 77 84
CRESTOR 79 67 79 29
RISPERIDONE 77 64 80 69
CARBIDOPA-LEVODOPA 76 76 81 114
LEVEMIR 75 40 82 157
DETROL LA 75 75 82 166
PROMETHAZINE HCL 75 56 R 82 75
HYDRALAZINE HCL 75 61 82 77
LYRICA 69 57 86 57
BACLOFEN 68 54 87 144
KLOR-CON M20 67 48 88 67
TRIAMCINOLONE ACETONIDE 65 48 89 191
PANTOPRAZOLE SODIUM 64 61 90 42
AMOXICILLIN 64 58 90 105
VERAPAMIL ER 63 50 92 101
LOVASTATIN 63 35 92 33
BENZTROPINE MESYLATE 62 36 R 94 129
PHENYTOIN SODIUM EXTENDED 59 30 95 88
TERAZOSIN HCL 59 58 95 145
METHYLDOPA-HYDROCHLOROTHIAZIDE 59 59 R 10 95 394
CELEBREX 58 58 98 108
QUINAPRIL HCL 58 54 98 151
DIOVAN HCT 57 51 100 41
LOSARTAN-HYDROCHLOROTHIAZIDE 57 53 100 51
IBUPROFEN 56 50 102 102
GLIPIZIDE XL 54 49 103 177
AMLODIPINE BESYLATE-BENAZEPRIL 54 54 103 44
TRAZODONE HCL 53 37 105 36
METRONIDAZOLE 52 47 106 293
INDAPAMIDE 52 47 106 188
FINASTERIDE 51 51 108 197
NITROSTAT 50 42 109 222
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.